Invivyd, Inc. (IVVD)
1.11
+0.02
(+1.83%)
USD |
NASDAQ |
May 21, 16:00
1.12
+0.01
(+0.90%)
After-Hours: 19:59
Invivyd Research and Development Expense (TTM) : 58.40M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| MannKind Corp. | 72.56M |
| Altimmune, Inc. | 66.69M |
| Cellectar Biosciences, Inc. | 11.08M |
| Karyopharm Therapeutics, Inc. | 124.57M |
| REGENXBIO, Inc. | 217.03M |